The role of endocrine-disrupting phthalates and bisphenols in cardiometabolic disease: the evidence is mounting Lucas, Andrew; Herrmann, Susan; Lucas, Michaela Lucas, Andrew; Herrmann, Susan; Lucas, Michaela Less Current Opinion in Endocrinology & Diabetes and Obesity. 29(2):87-94, April 2022. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Open
Polygenic risk scores for the diagnosis and management of dyslipidemia Brunham, Liam R.; Trinder, Mark Brunham, Liam R.; Trinder, Mark Less Current Opinion in Endocrinology & Diabetes and Obesity. 29(2):95-100, April 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy
HDL functionality in type 1 and type 2 diabetes: new insights Chapman, M. John Chapman, M. John Less Current Opinion in Endocrinology & Diabetes and Obesity. 29(2):112-123, April 2022. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Open
Gut-derived serotonin and its emerging roles in immune function, inflammation, metabolism and the gut–brain axis Banskota, Suhrid; Khan, Waliul I. Banskota, Suhrid; Khan, Waliul I. Less Current Opinion in Endocrinology & Diabetes and Obesity. 29(2):177-182, April 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy
